Story perspectives

Previvor Edge Raises $3.3M for Enhanced Cancer Prevention

10/10/2025

Summary

Story summary

Previvor Edge, co-founded by Michelle Zimmerman and Sven Karlsson, raised $3.3 million to enhance cancer prevention through improved patient education and risk management.
The New York-based company’s clinical program is in-network with major insurers, with over 90% of patients adjusting their prevention strategies based on early results.
Concurrently, researchers at the University of Toronto developed OncoGAN, an AI system that generates synthetic cancer genomes to improve diagnostic accuracy and treatment personalization while maintaining patient confidentiality.

1 of 1

Story summary

Previvor Edge, co-founded by Michelle Zimmerman and Sven Karlsson, raised $3.3 million to enhance cancer prevention through improved patient education and risk management.
The New York-based company’s clinical program is in-network with major insurers, with over 90% of patients adjusting their prevention strategies based on early results.
Concurrently, researchers at the University of Toronto developed OncoGAN, an AI system that generates synthetic cancer genomes to improve diagnostic accuracy and treatment personalization while maintaining patient confidentiality.